Evidence map›Paper›PMID 27408385›Full record

ArticleIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion2016

Complete Remission of Burkitt Lymphoma After Surgical Excision: A Case Report.

Huseyin Saffet Bekoz, Bulent Kantarcioglu, Tulay Tecimer, Necdet Uskent, Mustafa Cetiner, Burhan Ferhanoglu, Deniz Sargin

Open access · bronzeAbstract read
In one paragraph

Article in Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Huseyin Saffet BekozDivision of Hematology, Department of Internal Medicine, Istanbul Medipol University, Istanbul, Turkey.
Bulent KantarciogluDivision of Hematology, Department of Internal Medicine, Istanbul Medipol University, Istanbul, Turkey ; Medipol Mega Hospital Complex, Hematology Clinic, TEM Avrupa Otoyolu Goztepe Cikisi No:1, 34214 Bagcilar, Istanbul Turkey.ORCID 0000-0003-3060-721X
Tulay TecimerDepartment of Pathology, Acibadem University, Istanbul, Turkey.
Necdet UskentDepartment of Hematology-Oncology, Anadolu Medical Center, Istanbul, Turkey.
Mustafa CetinerDivision of Hematology, Department of Internal Medicine, Koc University, Istanbul, Turkey.
Burhan FerhanogluDivision of Hematology, Department of Internal Medicine, Koc University, Istanbul, Turkey.
Deniz SarginDivision of Hematology, Department of Internal Medicine, Istanbul Medipol University, Istanbul, Turkey.
Istanbul Medipol University · TRKoç University · TRAcıbadem University · TRAnadolu University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Burkitt lymphoma (BL) is a highly aggressive B cell non-Hodgkin lymphoma that has a high proliferation rate. The prognosis for BL is generally favorable, with cure rate of 75-90 % with modern chemoimmunotherapy regimens. Prompt administration of multiagent immunochemotherapy regimens is critical, because BL is almost always fatal if left untreated. Nevertheless here we report a case of BL that is still in complete remission after more than 4 years without any further treatment after surgical excision of the involved lymph node.

Identifiers

PMID27408385
PMCPMC4925554
OpenAlexW2297548386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.